PL1847258T5 - Częściowe glicerydy jako środki poślizgowe dla kompozycji farmaceutycznych zawierających pochodne tieno[3,2-c]pirydyny - Google Patents

Częściowe glicerydy jako środki poślizgowe dla kompozycji farmaceutycznych zawierających pochodne tieno[3,2-c]pirydyny

Info

Publication number
PL1847258T5
PL1847258T5 PL06007841T PL06007841T PL1847258T5 PL 1847258 T5 PL1847258 T5 PL 1847258T5 PL 06007841 T PL06007841 T PL 06007841T PL 06007841 T PL06007841 T PL 06007841T PL 1847258 T5 PL1847258 T5 PL 1847258T5
Authority
PL
Poland
Prior art keywords
thieno
lubricants
pharmaceutical compositions
pyridine derivatives
partial glycerides
Prior art date
Application number
PL06007841T
Other languages
English (en)
Other versions
PL1847258T3 (pl
Inventor
Thomas Beckert
Michael Braun
Klaus Neuer
Original Assignee
Acino Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36968494&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1847258(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Acino Pharma Ag filed Critical Acino Pharma Ag
Publication of PL1847258T3 publication Critical patent/PL1847258T3/pl
Publication of PL1847258T5 publication Critical patent/PL1847258T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL06007841T 2006-04-13 2006-04-13 Częściowe glicerydy jako środki poślizgowe dla kompozycji farmaceutycznych zawierających pochodne tieno[3,2-c]pirydyny PL1847258T5 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06007841A EP1847258B2 (de) 2006-04-13 2006-04-13 Partialglyceride als Schmiermittel für pharmazeutische Zusammensetzungen enthaltend Thieno[3,2-c]pyridin-Derivate

Publications (2)

Publication Number Publication Date
PL1847258T3 PL1847258T3 (pl) 2010-09-30
PL1847258T5 true PL1847258T5 (pl) 2013-06-28

Family

ID=36968494

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06007841T PL1847258T5 (pl) 2006-04-13 2006-04-13 Częściowe glicerydy jako środki poślizgowe dla kompozycji farmaceutycznych zawierających pochodne tieno[3,2-c]pirydyny

Country Status (8)

Country Link
EP (1) EP1847258B2 (pl)
AT (1) ATE464881T1 (pl)
CY (1) CY1110215T1 (pl)
DE (2) DE202006020892U1 (pl)
DK (1) DK1847258T4 (pl)
ES (1) ES2342965T5 (pl)
PL (1) PL1847258T5 (pl)
PT (1) PT1847258E (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE530172T1 (de) 2008-02-26 2011-11-15 Lesvi Laboratorios Sl Pharmazeutische formulierungen mit clopidogrel
KR101317809B1 (ko) 2011-06-07 2013-10-16 한미약품 주식회사 암세포의 성장을 억제하는 아마이드 유도체 및 비금속염 활택제를 포함하는 약학 조성물
KR20140096571A (ko) 2013-01-28 2014-08-06 한미약품 주식회사 1-(4-(4-(3,4-디클로로-2-플루오로페닐아미노)-7-메톡시퀴나졸린-6-일옥시)피페리딘-1-일)프로프-2-엔-1-온의 제조방법
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
CN104644595B (zh) * 2015-03-09 2017-10-24 吕霄芳 一种含有氯吡格雷的固体药物组合物
CN105362243B (zh) * 2015-12-18 2018-12-11 重庆福安药业(集团)股份有限公司 硫酸氢氯吡格雷口服固体药物组合物及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4591592A (en) 1980-07-29 1986-05-27 Syntex (U.S.A.) Inc. Acid stabilized compositions of thieno-pyridine derived compounds
US4490377A (en) * 1980-07-29 1984-12-25 Syntex (U.S.A.) Inc. Acid stabilized compositions of thieno-pyridine derived compounds
US4908210A (en) * 1988-10-28 1990-03-13 Eastman Kodak Company Lactylic salt tablet formulations and tablets
CA2100836C (en) 1993-07-19 1998-02-03 Bernard Charles Sherman PHARMACEUTICAL COMPOSITION
US5872128A (en) * 1997-10-15 1999-02-16 Invamed, Inc. Stabilized composition of ticlopidine hydrochloride
AU4288599A (en) 1998-07-01 2000-01-24 Sun Pharmaceutical Industries Ltd. Stable pharmaceutical compositions of thieno (3,2-c) pyridine derivatives
ES2149736T1 (es) * 1998-11-30 2000-11-16 Tecnimede Sociedade Tecnico Medicinal Sa Composiciones farmaceuticas conteniendo derivados de tienopiridina estables y libres de antioxidantes.
CA2363053C (en) 2001-11-09 2011-01-25 Bernard Charles Sherman Clopidogrel bisulfate tablet formulation
ATE374602T1 (de) 2001-12-21 2007-10-15 Supernus Pharmaceuticals Inc Orale kapselformulierung mit verbesserter physikalischer stabilität
WO2004098593A1 (en) 2003-05-05 2004-11-18 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate composition
ATE339192T1 (de) † 2003-05-14 2006-10-15 Eurand Pharmaceuticals Ltd Kontrollierte medikamentfreigabe zusammensetzung mit in vivo mechanikstresswiderstand
US20050095287A1 (en) * 2003-10-29 2005-05-05 Matharu Amol S. Fosinopril composition
GB0325603D0 (en) 2003-11-03 2003-12-10 Sandoz Ag Organic compounds
WO2005070464A2 (en) 2004-01-21 2005-08-04 Biofarma Ilac Sanayi Ve Ticaret A.S. A tablet formulation of clopidogrel bisulphate
IS2385B (is) † 2006-02-10 2008-07-15 Actavis Group Hf. Klópidógrel bísúlfat lyfjasamsetningar

Also Published As

Publication number Publication date
DE202006020892U1 (de) 2010-10-21
EP1847258B1 (de) 2010-04-21
ATE464881T1 (de) 2010-05-15
DK1847258T3 (da) 2010-08-09
EP1847258B2 (de) 2013-01-16
PT1847258E (pt) 2010-06-22
DK1847258T4 (da) 2013-04-15
PL1847258T3 (pl) 2010-09-30
DE502006006787D1 (de) 2010-06-02
ES2342965T3 (es) 2010-07-20
EP1847258A1 (de) 2007-10-24
CY1110215T1 (el) 2015-01-14
ES2342965T5 (es) 2013-04-03

Similar Documents

Publication Publication Date Title
CY1110215T1 (el) ΜΕΡΙΚΑ ΓΛΥΚΕΡΙΔΙΑ ΣΑΝ ΛΙΠΑΝΤΙΚΑ ΜΕΣΑ ΓΙΑ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΠΕΡΙΕΧΟΥΝ ΠΑΡΑΓΩΓΑ ΘΕΙΕΝΟ[3,2-c]ΠΥΡΙΔΙΝΗΣ
WO2008039472A3 (en) Stabilizing compositions for antibiotics and methods of use
EP2269582A3 (en) Multiparticulates of preferably an opioid, and method of manufacturing using extrusion
WO2008063910A3 (en) Method of preparing solid dosage forms of multi-phasic pharmaceutical compositions
WO2007077562A3 (en) Antiseptic compositions and methods of using same
WO2005108531A3 (de) Verwendung von polyalkyl(meth) acrylaten in schmierölzusammensetzungen
EP1610742A4 (en) METHODS AND COMPOSITIONS FOR ADMINISTERING TRPV1 AGONISTS
MA30765B1 (fr) Derives innovants du thiophene
ZA200705750B (en) Compositions and methods for stabilizing active pharmaceutical ingredients
WO2006127686A8 (en) Methods for managing release of one or more ingredients in an edible composition
WO2009055568A3 (en) Liposomal vancomycin formulations
IL196108A0 (en) Active agent formulations, methods of making, and methods of use
DOP2009000135A (es) Derivados de 2,3-dihidroimidazo [1,2-c] quinazolina sustituídos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogénesis
WO2007098128A3 (en) Phenylephrine-containing liquid formulations
CR7999A (es) Metodos y composiciones farmaceuticas para la obtencion confiable de niveles aceptables de testosterona en suero
MY147268A (en) Ketomethionine ketals and their derivatives
WO2008075231A3 (en) Diaper rash composition and method
IL206125A (en) Derivatives of 7-phenylamino pyrolo [2,1- c] pyrimidine-7-carboxylic acid, esters and their amides, and pharmaceutical preparations containing them
EP2279732A3 (en) Compounds and compositions for delivering active agents
NZ599292A (en) Vitamin d compositions and method of administration to a human being
IL163755A0 (en) Novel 1,2,3,-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing
WO2009038095A1 (ja) セサミン類とビタミンｂ１類とを配合した組成物
IL197452A (en) Annotations 3– [h1– pyrrolo [3,2– b] pyridin-3-ram)] methylidene] -imidazolidin-2-on and pharmaceutical preparations containing them as anti-proliferative substances
WO2007109587A3 (en) Compositions and methods for reducing inflammation and pain associated with acidosis
ZA200803574B (en) Dietary fiber formulation and method of administration